Ligand validation:4WF9

EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4WF9_EPE_L_201	53%	64%	0.126	0.887	0.77	0.58	1	-	0	0	100%	1
4WCE_EPE_X_3311	56%	56%	0.177	0.951	1.27	0.45	1	-	0	0	100%	1
5NRG_EPE_X_3285	51%	66%	0.195	0.949	0.54	0.74	-	1	0	0	100%	1
5HL7_EPE_N_201	39%	37%	0.202	0.909	1.14	1.39	1	2	16	0	100%	1
4WFA_EPE_X_3426	30%	18%	0.272	0.936	3.01	0.7	1	-	11	0	100%	0.9
4WFB_EPE_X_3423	11%	51%	0.311	0.827	1.05	0.86	1	1	1	0	100%	1
4WX4_EPE_A_302	99%	53%	0.064	0.994	0.99	0.82	1	-	0	0	100%	1
2F9R_EPE_B_701	99%	45%	0.061	0.989	0.62	1.54	-	2	0	0	100%	1
1VSI_EPE_A_261	98%	18%	0.058	0.984	1.64	2.09	1	6	1	0	100%	1
1XX1_EPE_D_2004	98%	29%	0.063	0.987	0.79	2.15	1	6	1	0	100%	1
4WYD_EPE_B_503	98%	45%	0.065	0.989	0.93	1.23	1	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.